Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2026-02-25 @ 4:16 AM
Study NCT ID:
NCT00095758
Status:
COMPLETED
Last Update Posted:
2013-11-25
First Post:
2004-11-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Sponsor:
Bristol-Myers Squibb
Organization:
Study Overview
Official Title:
A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: